Back to search

Canada· CA-DIN-02329743

DRAXIMAGE SODIUM IODIDE I131 CAPSULES, USP THERAPEUTIC

A sodium iodide (131i) product containing sodium iodide 131 i, registered in Canada by JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA. The same ATC class is registered in 9 of our 19 countries.

ATC V10XA01

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedDRAXIMAGE SODIUM IODIDE I131 CAPSULES…ATCV10XA01REGISTER NO.CA-DIN-02329743PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Sodium iodide (131i) is registered in 9 of 19 countries.

Countries holding a registration under ATC V10XA01 (sodium iodide (131i)), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 5 of them publish a price we can compare per daily dose

Sodium iodide (131i) · ATC V10XA01

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
SODIUM IODIDE 131 I
Manufacturer
JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Country
Canada (CA)
ATC code
V10XA01
ATC class
Sodium iodide (131I)
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/095ee6a7-33a7-493f-bf59-eb0d0c4e843f
GET /v1/drugs/095ee6a7-33a7-493f-bf59-eb0d0c4e843f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02329743",
  "form": "CAPSULE",
  "class": "Radiopharmaceutical",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "V10XA01",
  "schedule": [
    "Schedule C"
  ],
  "drug_code": "81546",
  "strengths": [
    "7400 MBq"
  ],
  "ahfs_class": null,
  "substances": [
    "SODIUM IODIDE 131 I"
  ],
  "product_categorization": null
}

See everything about sodium iodide (131i).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.